(HealthDay News) — For patients undergoing elective carotid artery stenting (CAS), stroke/death rates are similar with use of proximal embolic protection devices (P-EPDs) and distal filter embolic ...
Abbott Vascular Devices (Redwood City, CA) received FDA approval earlier this month for its Xact carotid stent and Emboshield embolic protection system. The device is intended to treat carotid artery ...
The recall was initiated following reports of 9 device malfunctions. Cardiovascular Systems Inc. has issued a voluntary recall of unused WIRION ® Embolic Protection systems due to complaints of filter ...
United States Embolic Protection Device Market is expected to reach US$ 650 million by 2033 from US$ 360 million in 2024, with a CAGR of 6.96% from 2025 to 2033. Rising cardiovascular operations, ...
A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...
Cardiovascular Systems Inc (CSI) has recalled its Wirion embolic protection device (Wirion) due to complaints that the filter may break during retrieval, according to a notice posted on the US Food ...
(MENAFN- EIN Presswire) EINPresswire/ -- The Embolic Protection Devices Market is gaining significant traction globally, driven by the rising prevalence of cardiovascular diseases, increasing adoption ...
TAVR is a less invasive cardiac procedure that treats patients with severe aortic stenosis without open heart surgery. While TAVR represents a major advance for patients, it carries a small but ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results